Compare EMBC & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMBC | INFU |
|---|---|---|
| Founded | 1924 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.9M | 197.0M |
| IPO Year | 2021 | 2005 |
| Metric | EMBC | INFU |
|---|---|---|
| Price | $5.15 | $12.41 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $18.50 | $15.00 |
| AVG Volume (30 Days) | ★ 1.6M | 173.4K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.88% | N/A |
| EPS Growth | 20.90 | ★ 181.82 |
| EPS | ★ 1.03 | 0.20 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | $1.17 | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ $4.96 | $62.40 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $2.77 | $7.29 |
| 52 Week High | $15.55 | $12.97 |
| Indicator | EMBC | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 74.48 | 68.17 |
| Support Level | $3.01 | $8.40 |
| Resistance Level | $9.38 | $12.97 |
| Average True Range (ATR) | 0.31 | 0.70 |
| MACD | 0.17 | 0.25 |
| Stochastic Oscillator | 96.51 | 86.80 |
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.